Accessibility StatementSkip Navigation NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Sotherly Hotels Inc. (NASDAQ: SOHO) related to its sale to KW Kingfisher LLC. Under the ter ...

Oct 27, 2025 5:02 PM Eastern Daylight TimeSOHO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sotherly Hotels Inc. Is Fair to ShareholdersShareShareholders should contact the firm immediately as there may be limited time to enforce your rights.NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sotherly Hotels Inc. (NASDAQ: SOHO) to KW Kingfisher LLC for $2.25 per share in cash is fair to Sotherly shareholders.Halper Sadeh encour ...

WILLIAMSBURG, Va., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) today announced that it is deferring payment of its previously announced dividends for its Series B Cumulative Redeemable Perpetual Preferred Stock, Series C Cumulative Redeemable Perpetual Preferred Stock, and Series D Cumulative Redeemable Perpetual Preferred Stock that were to be paid November 20, 2025, to shareholders of record as of October 31, 2025. In connection with that payment deferral, the Oct ...

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sotherly Hotels Inc. (NASDAQ: SOHO) to KW Kingfisher LLC for $2.25 per share in cash is fair to Sotherly shareholders. Halper Sadeh encourages Sotherly shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Sother ...

WILLIAMSBURG, Va., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (Nasdaq: SOHO) (“Sotherly” or the “Company”) today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with a joint venture led and sponsored by affiliates of Kemmons Wilson Hospitality Partners, LP (“KWHP”), with Ascendant Capital Partners LP (“Ascendant”) serving as a strategic joint venture partner (collectively, the “Joint Venture”), under which the Joint Venture entity, KW Kingfisher LLC, wil ...

WILLIAMSBURG, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) announced that the Company will report financial results for the third quarter 2025 prior to the market opening on Thursday, November 13, 2025. A conference call for investors and other interested parties is scheduled for 10:00 a.m. Eastern Time (ET) that same day, at which time management will discuss the Company’s third quarter 2025 results. The information to be discussed on the call will be contained ...

融资活动 - 公司执行4200万美元担保贷款 由花旗房地产融资公司提供 [1] - 贷款以佐治亚州萨凡纳DeSoto酒店的第一抵押权作为担保 [1] 市场反应 - 公司股价出现大幅上涨 [1]

融资活动 - 公司执行了一笔4200万美元的由花旗房地产融资公司提供的担保贷款 [1] - 该笔贷款为仅付息贷款 本金4200万美元 期限至2030年10月6日 固定利率为7.13% [1] - 贷款收益用于偿还现有第一抵押权债务及一般公司用途 [1] 管理层评论 - 公司首席执行官表示此次对历史悠久的DeSoto Savannah酒店的成功再融资是资产重置战略的顶点 [2] - 该资产重置战略始于2017年向独立生活方式的转型 为酒店和股东创造了巨大价值 [2] 公司概况 - 公司是一家自我管理和自我经营的住宿类房地产投资信托基金 专注于收购、翻新、品牌升级和重新定位美国南部的高档至超高档全服务酒店 [2] - 公司目前投资组合包括10家酒店物业 共计2786间客房 以及两家分时度假酒店及其相关租赁项目的权益 [2] - 公司旗下酒店品牌包括希尔顿和凯悦 也拥有独立品牌酒店 总部位于弗吉尼亚州威廉斯堡 [2]

收购交易结构 - 投资集团MCR与Soho House执行主席提出以每股9美元现金收购Soho House & Co Inc (NYSE: SHCO) [2] - 交易公告日期为2025年8月18日 [2] 潜在利益冲突 - 执行主席Ron Burkle计划将其股权转入交易后的私有公司 而少数股东将以每股9美元被现金收购且无法享有未来收益 [3] - 律师事务所调查发现交易过程及对价存在显著不公平迹象 [3] 法律介入情况 - Kaskela Law LLC正对收购案展开调查 以评估其对投资者的公平性 [1] - 该律所专精证券欺诈、公司治理及并购诉讼 并邀请股东联系以了解法律权益 [4]

临床数据发布 - 公司将在2025年9月3-6日于休斯顿举行的SOHO年会上以口头和海报形式展示ELVN-001的ENABLE 1a/1b期临床试验数据 [1] - 本次为欧洲血液学协会（EHA）2025年会数据的再次展示 涉及对既往接受过治疗的慢性髓系白血病患者的研究 [1][2] - 口头报告安排在9月4日11:40-11:50（CDT时段） 海报展示于9月3日18:25进行 编号CML-575 位于B3展厅3层 [2] 产品研发进展 - ELVN-001是一种选择性BCR::ABL1活性位点抑制剂 针对慢性髓系白血病治疗领域 [2] - 公司采用精准肿瘤学方法开发小分子疗法 致力于解决未满足的临床需求并提升患者生存质量 [3] - 研发策略结合经临床验证的生物学靶点洞察与差异化化学设计 以开发同类首创或同类最优疗法 [3] 企业背景 - Enliven Therapeutics为临床阶段生物制药企业 专注于小分子治疗药物的发现与开发 [1][3] - 公司总部位于科罗拉多州博尔德 目前于纳斯达克交易所上市（代码：ELVN） [1][3] - 演示资料会后将发布于公司官网"项目演示与出版物"栏目供查阅 [2]